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Exposure  to  developmental  toxins  during  gestation  have  been  shown  to  be  linked  to  neurological  
disorders  such  as  epilepsy,  schizophrenia,  and  dyslexia  [1] .  In  this  report  we  describe  efforts  that  
represent  the  ground  work  to  develop  a  predictive  neurotoxicity  model  to  test  developmental  
toxicity  on  early  neuronal  differentiation  from  drugs  and  toxins  for  human  consumption  or  
exposure.  Developmental  toxins  are  toxins  that  prevent  stem  cell  differentiation  into  neurons  by  
impacting  neural  development  [2] .  Currency  technologies  used  to  evaluate  a  compound's  
potential  as  a  developmental  toxin  are  centered  around  culturing  stem  cells  in  a  two-dimensional  
environment  or  exposing  animal  models  to  the  compound.  The  stem  cells  are  then  monitored  for  
changes  in   proliferation,  differentiation,  and  death.  These  classes  of  experiments  proved  not  
only  to  be  expensive,  but  also  extremely  time  consuming  and  ineffective  in  some  cases.  These  
technologies  do  not  accurately  mimic  the  in  vivo  environment,  which  uses  ECM  proteins  and  
cell-cell  interactions  to  regulate  cellular  functions  such  as  migration,  apoptosis,  and  gene  
expression.  Our  predictive  model  would  provide  a  more  biologically  accurate  alternative  of  the  
human  system  compared  to  two-dimensional  cell  culture  and  animal  models.  Our  model  would  
further  improve  the  quality  and  relevance  of  developmental  neurotoxicity  research,  reduce  the  
number  of  animal  experiments  and  overall  cost  to  evaluate  the  potential  for  a  compound  to  act  as  
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CHAPTER  1:  Introduction  
1.1  Introduction  
For  our  Senior  Design  project,  we  worked  towards  designing  a  predictive  model  to  identify  
neurotoxic  compounds,  particularly  focusing  on  developmental  neurotoxins.  Developmental  
toxins  prevent  stem  cell  differentiation  into  neurons  by  impacting  neural  development  through  
many  possible  avenues,  such  as  by  damaging  DNA,  impacting  gene  expression,  modifying  
signaling  proteins,  and  many  others  [2] .  This  type  of  toxicity  is  distinct  from  stem  cell  toxins,  
which  are  those  that  are  cytotoxic  to  stem  cells,  and  neurotoxins,  which  are  either  cytotoxic  or  
functional  toxins  to  neurons.  We  are  interested  in  studying  developmental  neurotoxins  due  to  
their  profound  impact  on  brain  development,  and  therefore  on  people’s  lives.  In  the  US,  about  
one  in  six  children  are  affected  by  developmental  disabilities,  many  of  which  are  related  to  
neurological  development  [3] .  The  exposure  of  the  brain  to  various  agents  can  lead  to  
developmental  neurotoxicity.  These  alterations  can  have  long-lasting  impacts,  such  as  causing  a  
number  of  other  neurological  disorders,  like  epilepsy,  schizophrenia,  and  dyslexia  [4] .  Many  
commonly-found  agents,  such  as  metals  like  lead  and  mercury,  pesticides,  nicotine  and  ethanol,  
are  known  developmental  toxins  [2] .  The  EPA  estimates  that  less  than  1%  of  chemicals  in  the  
environment  have  been  tested  for  developmental  neurotoxic  effects  due  to  slow  and  expensive  
testing  [1] .  The  prevalence  of  developmental  neurotoxins  in  our  environment,  along  with  the  
profound  impact  these  toxins  can  have  on  individuals  and  communities  highlights  the  need  for  an  
increased  understanding  and  awareness  of  developmental  neurotoxicity.  With  our  model,  we  
hope  to  make  it  easier  to  identify  and  study  developmental  neurotoxins,  thus  helping  to  reduce  
their  impact.  
  
Currently,  neurotoxicity  testing  uses  several  2D  assays  to  test  toxicity  of  compounds  for  human  
topical  use,  consumption  and  exposure  [5] .  Existing  assays,  such  as  cytotoxicity,  cell  viability,  
and  functional  assays  as  well  as  qPCR  and  cell  morphology,  utilize  stem  cells,  stem  cell  derived  
neurons  and  cultured  neurons  to  analyze  the  impact  of  toxins  on  cell  fates  [6–9] .  While  the  
previous  technologies  discussed  are  useful,  cell  culture  experiments  represent  a  very  costly  class  
of  experiments  that  do  not  always  produce  reliable  results.  For  this  reason,  we  propose  creating  a  
model  based  upon  data  collected  from  3D  culture  systems  in  order  to  predict  the  cellular  fate  of  
early  neurons.  By  studying  developmental  toxicity  in  3D,  we  can  overcome  the  limitations  of  2D  
culture,  which  does  not  mimic  in  vivo  cell-cell  and  cell-matrix  interactions  [10] .  This  would  
allow  the  production  of  data  that  better  represents  the  in  vivo  environment  in  order  to  make  more  
sound  predictions  about  the  microenvironmental  factors  that  influence  early  neuronal  
differentiation.  While  data  included  in  this  report  is  focused  on  neuronal  differentiation,  we  
postulate  that  the  methods  developed  could  be  applied  to  various  cell  types.  
  
1.2  Background  and  Literature  Review  
1.2.1  Why  3D  Culture? 
Cell  culture  is  an  indispensable  tool  in  areas  of  developmental  biology,  tissue  engineering,  and  
protein  pharmaceutical  production.  All  early  cell  culture  techniques  are  composed  of  
two-dimensional  environments,  where  cells  attach  to  plastics  or  extracellular  matrix  (ECM)  
attachment  molecules  shown  in  Figure  1.  In  vivo,  cells  are  in  constant  interaction  with  a  variety  
of  ECM  molecules  that  regulate  cellular  functions  (migration,  apoptosis,  gene  expression,  etc)  
which  cannot  be  fully  represented  in  the  2D  environment  [10] .  The  current  drug  development  
pipeline  costs  anywhere  from  $800  million  to  $2  billion  and  can  take  up  to  15  years  to  bring  to  
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market  [10] .  The  process  begins  with  a  screening  of  compounds  in  a  2D  cell  culture  
environment,  followed  by  animal  models  and  finally  human  clinical  trials.  This  pipeline  only  
brings  approximately  10%  of  initial  leads  through  clinical  development.  Additionally,  some  
therapeutics  make  it  all  the  way  to  phase  III  clinical  trials  before  proving  inefficacious,  at  which  
point  millions  of  dollars  have  already  been  allocated  to  research  and  development.  A  rapidly  
growing  field  of  literature  has  suggested  that  3D  cell  culture  systems  promise  to  address  these  
challenges  by  providing  cells  a  more  realistic  extracellular  environment  shown  in  Figure  1  [10] .   
  
  
Figure  1:  Typical  2D  (Left)  and  3D  (right)  polymer  matrix  culture  systems  (adapted  from  [11] )  
  
3D  culture  has  been  shown  to  produce  superior  and  more  relevant  results  compared  to  2D  in  a  
variety  of  applications.  One  example  is  when  cell  culture  systems  are  used  as  a  model  for  drug  
development,  various  studies  have  illustrated  that  pharmacaiduals  that  show  promise  in  2D  have  
reduced  or  no  efficacy  when  tested  in  3D  culture  systems.  For  example,  a  study  performed  by  
Edmonson  et.  al .  showed  that  an  anti  cancer  drug,  Melphalan,  killed  ~100%  of  an  intestinal  
cancer  cell  line  at  concentrations  of  100uM  but  when  the  same  concentration  of  the  drug  was  
tested  in  a  3D  spheroid  culture  system  only  ~20%  of  the  cells  were  killed  [12] .  These  results  
indicate  the  need  for  cell  culture  techniques  that  better  represent  the  invivo  environment.  As  3D  
culture  platforms  offer  a  more  robust  way  to  culture  cells  and  study  their  cellular  functions,  it  
represents  a  new  modality  to  understand  the  effect  of  compounds  on  the  differentiation  of  stem  
cells  to  early  neurons.  
  
1.2.2  Existing  Technologies  
Currently,  neurotoxicity  testing  uses  several  2D  assays  to  test  toxicity  of  compounds  for  human  
topical  use,  consumption  and  exposure  [5] .  Existing  assays,  such  as  cytotoxicity,  cell  viability,  
and  functional  assays  as  well  as  qPCR  and  cell  morphology,  utilize  stem  cells,  stem  cell  derived  
neurons  and  cultured  neurons  to  analyze  the  impact  of  toxins  on  cell  fates  [6–9] .  The  next  several  
subsections  will  elaborate  on  specific  examples  of  these  2D  neurotoxicity  assays  and  the  type  of  
data  collected.   
  
1.2.2.1  Cytotoxicity  and  Cell  Viability  Assays  
Succinate  dehydrogenase  activity  assay,  also  known  as  a  MTT  assay,  is  a  common  cytotoxicity  
colorimetric  assay  that  measures  cell  viability  and  proliferation  by  enzymatically  reacting  with  
succinate  dehydrogenase  in  the  mitochondria  [13] .  Essentially,  the  occurrence  of  mitochondrial  
respiration  catalyzes  the  reduction  of  the  MTT  dye  into  insoluble  crystals  [13] .  Color  produced  
from  the  cells  is  proportional  to  the  number  of  viable  cells  after  the  cells  are  lysed  and  processed 
[13] .  A  great  example  of  a  cell  viability  assay  is  dye  exclusion.  This  test  allows  researchers  to  
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determine  the  number  of  viable  cells  and  dead  cells  [14] .  Dyes,  such  as  trypan  blue,  eosin  or  
propidium,  are  introduced  into  a  cell  suspension  and  will  only  dye  cells  without  intact  cellular  
membranes  [14] .  Since  viable  cells  have  intact  membranes,  they  will  remain  clear  while  dead  
cells  are  dyed  [14] .  Using  a  hemocytometer,  researchers  can  count  a  small  fraction  of  the  overall  
cell  suspension  and  calculate  an  estimate  for  the  overall  number  of  viable  and  dead  cells  [14] .  
MTT  assays  and  dye  exclusion  allows  researchers  to  determine  the  dose-  and  time-dependent  
cytotoxic  effect  of  their  drug  or  compound  of  interest  [13,14] .   
  
1.2.2.2  Functional  Assays  
Functional  assays  measure  the  neuron’s  ability  to  function,  such  as  generating  action  potentials  
or  creating  calcium  influxes  to  release  neurotransmitters  [15,16] .  Two  commonly  used  functional  
assays  are  calcium  imaging  and  patch  clamp  recording.  Calcium  imaging  is  used  to  analyze  
neuronal  signaling  by  allowing  researchers  to  image  or  record  the  occurrence  of  action  potentials  
in  neurons  [15] .  Calcium  is  used  by  neurons  in  their  axon  terminals  to  trigger  exocytosis  of  
neurotransmitters,  releasing  them  into  the  synaptic  cleft  and  passing  the  signal  to  postsynaptic  
neurons  [15] .  In  order  to  capture  neuron  signaling,  a  bioluminescent  calcium  indicator  such  as  
aequorin,  derived  from  bioluminescent  marine  organisms,  or  chemical  calcium  dyes  are  used.  
Due  to  aequorin’s  large  size  it  must  be  loaded  into  each  cell  by  a  micropipette  or  transfected  into  
the  cells  via  genetic  engineering  [15] .  Similarly,  chemical  dyes  need  to  be  introduced  by  
micropipettes.  Once  introduced,  neuronal  signalling  can  be  imaged  by  high-speed  confocal  
microscopes  [15] .   
   
Patch  clamp  recording  is  another  type  of  functional  assay  to  measure  neuron  activity.  It  can  be  
performed  on  single  neurons,  brain  slices  or  live  brains  in  sedated  animals  [16] .  Researchers  
place  a  glass  micropipette  electrode  directly  on  a  small  area  of  the  cell  membrane  and  use  suction  
to  firmly  seal  the  tip  of  the  pipette  to  the  cell  [16] .  As  the  cellular  membrane  changes  voltage  
during  action  potentials,  the  electrode  will  be  able  to  record  the  change  in  voltage.  The  tight  seal  
creates  very  high  resistance,  allows  detection  of  small  voltage  changes  and  blocks  external  
currents  from  surrounding  cells  [16] .  This  method  allows  researchers  to  measure  the  neuronal  
activity  of  individual  cells  [16] .  
  
1.2.2.3  Gene  and  Protein  Expression  
Reverse  Transcription  Polymerase  Chain  Reaction  (RT-PCR),  Western  Blots  and  
Immunocytochemistry  allow  researchers  to  analyze  the  gene  and  protein  expression  of  cells  as  a  
result  of  exposure  to  drugs  or  environmental  compounds  [17,18] .  Researchers  can  identify  cell  
differentiation,  maturity  and  up/down  regulation  of  a  gene  or  protein  of  interest  [17,18] .   
  
RT-PCR  identifies  and  magnifies  the  presence  of  genes  of  interest  allowing  the  comparison  of  
gene  expression  pre-  and  post-exposure  to  the  compound  [17] .  After  cells  have  been  exposed  to  
the  compound,  mRNA  is  isolated  and  prepped  for  RT-PCR.  Primers  are  selected  to  identify  key  
genes  for  cell  fate,  such  as  beta  3  tubulin  which  is  a  marker  for  immature  neurons  [18]  or  MAP2  
which  is  a  marker  for  mature  neurons  [17] .  During  RT-PCR,  the  mRNA  is  reverse  transcribed  
into  cDNA,  which  is  then  amplified  by  taq  polymerase  [17] .  The  chosen  primers  will  only  bind  
to  complementary  sequences  on  the  cDNA,  amplifying  the  genes  of  interest  to  detectable  levels  
[17] .  Researchers  can  use  either  gel  electrophoresis  or  primers  with  a  fluorescent  tag  to  detect  the  
gene  [17] .   
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Western  Blots  are  used  to  detect  the  presence  of  a  protein  of  interest  [18] .  After  compound  
exposure,  the  cells  are  lysed  and  processed  to  isolate  protein.  A  BCA  protein  assay  is  used  to  
determine  overall  protein  concentration  [18] .  Then,  gel  electrophoresis  is  used  to  separate  the  
protein  mixture  and  transferred  to  a  PVDF  membrane  to  be  stained  with  antibodies  to  detect  the  
protein  of  interest  [18] .  To  detect  fluorescence  from  the  antibody  stain  a  fluorescence  
microscope,  such  as  a  confocal  microscope,  is  used  [18] .  Images  are  taken  of  the  membrane  and  
image  processing  software  is  used  to  analyze  protein  expression  [18] .  
  
Immunocytochemistry  is  another  technique  to  detect  the  presence  of  a  protein  of  interest.  After  
cells  are  exposed  to  the  toxin,  they  are  fixed  with  paraformaldehyde  and  stained  with  fluorescent  
primary  and  secondary  antibodies  for  specific  proteins  of  interest  [18] .  Multiple  proteins  can  be  
stained  at  the  same  time.  Similar  to  western  blots,  a  fluorescence  microscope  is  used  to  image  the  
cells  and  an  image  processing  software  is  used  to  analyze  protein  expression  [18] .  
Immunocytochemistry  produces  similar  results  as  western  blots  in  addition  to  allowing  
researchers  to  identify  the  protein  location  in  the  cell  and  morphology  [18] .  
  
1.2.2.4  Morphology   
Lastly,  morphology  can  be  used  to  identify  the  effect  of  the  neurotoxin  on  stem  cells  or  neurons.  
Researchers  can  measure  the  change  in  cell  size,  fragment  length  per  cell,  branches  per  cell,  and  
total  length  per  cell  [19] .  These  morphological  changes  indicate  the  impact  of  the  toxin  on  
cellular  differentiation  and  signs  of  cytotoxicity  [19] .  For  instance,  Crumpton  et.  al.  used  
morphology  in  their  study  to  identify  the  most  sensitive  period  during  differentiation  for  which  
the  toxin  had  the  greatest  effects  on  the  stem  cells  [19] .  They  concluded  that  lead  had  the  greatest  
effect  during  the  early  initiation  events  of  differentiation  [19] .  Although  morphology  is  the  
simplest  neurotoxicity  detection  platform  explored  in  this  section,  it  is  a  cheap  and  powerful  tool  
that  should  not  be  ignored.   
  
1.3  Proposed  Goals  
1.3.1  Mission   
Our  mission  is  to  develop  a  three-dimensional  neurotoxicity  platform  to  test  developmental  
toxicity  on  early  neuronal  differentiation  from  drugs  and  toxins  for  human  consumption  or  
exposure.  Our  model  will  provide  a  more  biologically  accurate  alternative  of  the  human  system  
compared  to  animal  models,  currently  used  for  clinical  and  pharmaceutical  research.  
  
1.3.1  Initial  Project  Goals  
During  the  spring  and  summer  of  2020,  we  designed  our  initial  project  to  be  performed  
completely  in  the  lab.  Our  goal  was  to  design  a  3D  cell  culture  system  to  test  the  developmental  
neurotoxicity  effect  of  acrylamide  on  neural  differentiation.  In  order  to  perform  this  experiment,  
we  would  culture  and  differentiate  P19  cells  in  3D  alginate  hydrogels.  At  various  time  points  
during  differentiation,  different  concentrations  of  acrylamide  would  be  added  to  the  system.  
Then,  we  would  analyze  the  morphological  changes  using  microscopes,  imaging  and  image  
analysis  as  well  as  cell  proliferation.  
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1.3.2  Revised  Project  Goals  Due  to  COVID-19  
As  a  result  of  COVID-19,  our  project  has  gone  through  a  number  of  revisions.  Our  initial  project  
would  have  been  largely  conducted  in  the  lab.  However,  we  realized  over  the  summer  prior  to  
our  senior  that  this  would  not  be  feasible  due  to  COVID-19,  so  we  created  the  initial  project  
goals  outlined  above.  These  goals  still  relied  on  some  lab  time,  though,  and  by  the  end  of  Fall  
2020,  it  became  clear  that  we  would  not  be  able  to  complete  any  meaningful  work  in  the  lab  due  
to  the  lab  restrictions.  At  this  time,  we  created  revised  project  goals.  The  revised  projects  goals  
are  as  follows:   
1. Collect  data  from  literature  on  how  various  factors  affect  neural  differentiation,  to  
identify  factors  that  have  an  impact  on  neural  differentiation.  
2. Analyze  the  combined  data  collected  from  literature  using  G-Tests,  χ 2 -tests  and  logistic  
regression  to  determine  significance  of  these  factors  to  show  the  effect  of  the  variables  on  
differentiation.  Analyze  large  data  sets  using  other  techniques  such  as  Principal  
Component  Analysis  (PCA).  
3. Combine  significance  tests  and  other  data  analysis  into  a  model  to  inform  future  research  
into  developmental  neurotoxicity  tests  in  3D  culture.  
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CHAPTER  2:  Project  Overview   
2.1  System  Overview  
In  order  to  collect  data  to  use  in  our  model,  we  followed  a  general  procedure  that  took  place  in  
three  steps:  literature  review,  data  collection  and  unification,  followed  by  statistical  hypothesis  
testing.  An  initial  literature  review  and  data  collection  consisting  of  50  articles  regarding  7  
different  variables  known  to  influence  neural  differentiation  was  narrowed  down  to  14  articles  
regarding  three  different  variables:  2D  vs  3D  culture  environment,  toxin  presence,  and  matrix  
stiffness  outlined  in  Table  1.  The  final  data  set  used  for  statistical  analysis  was  chosen  due  to  
their  most  comparable  experimental  setups  and  data  collection  methods.  
  
We  performed  𝜒 2 -test(s),   G-Test(s)  of  Independence,  Logistic  Regression,  and  PCA  on  some  or 
all  of  the  subsystem  variables  depending  on  the  suitability  of  each  data  set  outlined  in  Table  1.  
All  of  the  statistical  tests  performed  were  used  to  determine  if  there  is  or  is  no  association  
between  the  subsystem  variable  and  neural  differentiation  with  the  exception  of  the  PCA  
analysis.  The  PCA  analysis  was  performed  to  reduce  the  dimensionality  of  one  of  the  datasets  
from  the  stiffness  subsystem  variable  (see  section  5.2.2.2).  
  
Table  1:  Outline  of  Subsystem  Data  Collection  and  Analysis  
  
  
Sub  System  Data  source  /  Number  of  Articles  
Used  
Statistical  Tests  
Used  
Hypotheses  
2D  vs  3D  
  
1.  Huang  et  al.,  Neuro  Regen  Res  
(2013)  
2.  Brannvall  et  al,  Journal  of  
Neuroscience  Research  (2007)  
3.  Zare-Mehrjardi  et  al.,  Int  J  Artif  
Organs  (2011)  
4.  Bozza  et  al.,  Biomaterials  (2014)  
5.  Oritinau  et  al.,  BioMedical  
Engineering  OnLine  (2010)  
1.  Chi  Square  Test  





Null  Hypothesis:  
There  is  no  
association  between  
the  subsystem  








There  is  an  
association  between  
the  subsystem  
variable  and  neural  
differentiation.  
Toxin  1.  Engstrom  et  al.,  Toxicol  In  Vitro  
(2016)  
2.  Lin  et  al.,  Chemosphere  (2021)  
3.  Tasneem  et  al.,  Toxicol  Lett  (2016)  
1.  𝜒 2 -test  
2.  G-Test  
Stiffness  
  
1.  Banerjee  et  al.,  Biomaterials  (2009)  
2.  Leipzig  et  al.,  Biomaterials  (2009)  
3.  Rammensee  et  al.,  Stem  Cells  
(2017)  
4.  Ali  et  al.,  Acta  Biomaterialia  (2015)  
5.  Her  et  al.,  Acta  Biomaterialia  
(2013)  
6.  Engler  et  al.,  Cell  (2006)  
  
1.  𝜒 2 -test  
2.  G-Test  
3.  Logistic  
Regression  
4.  PCA  
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2.1.1  2D  versus  3D  
One  factor  we  investigated  was  two-dimensional  versus  three-dimensional  matrices.  As  outlined  
in  section  1.2.1,  various  research  groups  have  found  that  cells  cultured  in  3D  matrices  have  a  
higher  rate  of  stem  cell  differentiation  as  well  as  cell  survival  and  proliferation  [20–25] .  We  
investigated  the  significance  of  the  impact  of  matrix  dimensions  on  stem  cell  differentiation  
using  a  𝜒 2 -test.  
  
2.1.2  Toxin  
Research  has  shown  that  compounds  that  do  not  act  as  cytotoxins  can  still  act  as  neural  toxins.  
However,  the  EPA  estimates  that  less  than  1%  of  chemicals  in  the  environment  have  been  
evaluated  for  their  potential  to  cause  developmental  neurotoxicity  [1] .  For  this  reason,  in  addition  
to  investigating  the  influence  of  2D  and  3D  matrices  on  neuronal  differentiation,  we  also  
investigated  the  effect  of  particular  toxins  on  neuronal  differentiation,  proliferation,  and  death.  
Data  was  collected  on  the  effect  of  Acrylamide  and  Lead  exposure  on  cellular  characteristics  
such  as  gene  expression  and  cellular  morphology  and  was  analyzed  for  significance  using  𝜒 2   and  
G-tests.  
  
2.1.3  Stiffness  
Another  factor  that  we  investigated  in  regards  to  neuronal  differentiation  was  matrix  stiffness.  A  
wide  variety  of  researchers  have  investigated  the  impact  of  stiffness  on  stem  cell  differentiation.  
Overall,  researchers  have  found  that  lower  stiffnesses,  like  that  of  the  brain,  cause  stem  cells  to  
differentiate  into  neurons  [26–34] .  Due  to  its  importance,  we  wanted  to  incorporate  the  impact  of  
stiffness  into  our  predictive  models.  We  investigated  the  impact  of  stiffness  on  differentiation  by  
combining  various  datasets  collected  from  literature,  analyzed  them  with  statistical  techniques  to  
determine  significance,  and  completed  Principle  Component  Analysis  (PCA).  
  
2.2  Systems  Integration  
The  overall  goal  of  this  project  was  to  create  two  models,  as  shown  in  Figure  2.  The  first  would  
input  microenvironment  cues  (2D  vs.  3D,  stiffness,  and  developmental  toxin),  and  output  cell  
fate.  The  second  would  input  cell  characteristics  (morphology,  cell  viability  and  proliferation,  
and  gene  or  protein  expression)  and  output  toxin  type  (developmental,  neuronal,  stem  cell  or  no  
toxin).  In  order  to  create  these  models,  we  would  need  to  do  further  data  collection  and  lab  work. 
  
Figure  2:  Diagram  of  the  Predictive  Models  
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2.3   Team  and  Project  Management  
2.3.1  Schedule  
Due  to  COVID-19,  we  had  to  shift  to  an  entirely  virtual  project  at  the  end  of  fall  quarter.  As  a  
result,  we  spent  time  during  the  fall  working  on  preparing  for  lab  work  as  well  as  developing  our  
model  before  pivoting  to  solely  working  on  modeling  in  the  winter  and  spring.  In  fall  2020,  we  
completed  literature  review,  applied  for  funding,  determined  materials  to  purchase,  and  began  
data  collection  from  literature.  In  winter  2021,  we  continued  to  collect  data,  began  to  analyze  our  
data  using  contingency  tables  (χ 2 -tests,  G-tests,  and  linear  regression),  and  PCA,  reviewed  
mathematical  models  in  biological  systems,  and  began  to  write  our  thesis.  In  spring  2021,  we  
completed  our  statistical  analyses,  senior  design  presentation  and  thesis.  See  the  Gantt  Chart  in  
the  Appendix  D  for  an  overview  of  our  progress  throughout  the  year  (Figure  11).  
  
2.3.2  Budget  and  Materials  
In  the  beginning  of  the  year,  we  planned  to  perform  lab  experiments  as  outlined  in  section  1.3.1  
and  submitted  our  proposed  budget  for  funding  from  Santa  Clara  University  School  of  
Engineering  located  in  Appendix  C  (Table  19  and  Table  20).  Due  to  COVID-19  restrictions,  we  
transitioned  our  project  Winter  quarter  2021  to  a  fully  virtual  format.  Table  21  in  Appendix  C  
outlines  the  finalized  list  of  materials  and  cost.  
  
2.3.31  Challenges  
Throughout  our  project,  we  have  run  into  issues  related  to  obtaining  raw  data  from  articles,  
determining  a  similar  metric  across  articles  and  the  COVID-19  pandemic.  The  largest  challenge  
was  determining  the  feasibility  of  our  original  project  due  to  COVID-19  restrictions.  We  
originally  wanted  to  perform  laboratory  experiments  on  the  effects  of  acrylamide  toxicity  on  
neuronal  differentiation  in  2D  versus  3D  culture  conditions  using  imaging  and  software  to  
quantify  differentiation.  During  Fall  quarter,  our  team  was  not  able  to  access  the  lab  but  focused  
on  collecting  protocols,  researching  background  information  for  our  project  and  collecting  data  
for  a  predictive  model.  Unfortunately,  a  second  stay-at-home  order  was  put  into  effect  in  
December,  preventing  Dr.  Asuri  from  beginning  to  culture  cells  for  our  experiments  and  
restricting  our  access  during  the  Winter  quarter.  We  transitioned  our  project  scope  to  a  fully  
computational  project  focusing  on  our  predictive  mathematical  models.  
  
To  formulate  our  model,  we  gathered  data  from  other’s  previous  research  on  our  variables  of  
interest.  Often  the  data  was  presented  in  graphs,  requiring  us  to  estimate  the  values  using  a  grid  
overlay,  mentioned  in  Chapter  3.  During  the  Fall  quarter,  we  emailed  numerous  laboratories  for  
access  to  their  raw  data,  but  only  one  replied,  proving  it  hard  to  obtain  raw,  high  quality  data  for  
our  model.  Of  the  data  we  did  collect,  the  metric  for  measuring  each  experiment  varied  by  paper.  
Some  researchers  used  normalized  mRNA  gene  expression  from  RT-PCR,  protein  expression,  
percent  cells  differentiated,  percent  cells  positive  for  a  marker,  fluorescence,  change  in  neuron  
cell  body  area,  number  of  neurite  branches  or  neurite  extension  length  to  analyze  the  change  in  
neuronal  differentiation.  We  struggled  to  find  a  common  metric  across  articles  to  be  able  to  
compare  data  between  the  papers  for  one  variable.  For  instance,  we  collected  papers  analyzing  
the  effect  of  matrix  stiffness  on  differentiating  stem  cells.  A  common  metric  among  several  of  
the  papers  was  the  normalized  expression  of  beta  3  tubulin.  That  selected  data  was  then  used  in  
our  contingency  tables  and  expected  value  tables  were  created  to  perform  𝜒 2 -test  and  G-test.  For  
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several  of  our  variables,  the  expected  values  were  less  than  5  going  against  the  general  rule  of  
thumb  for  a  successful  test.   
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CHAPTER  3:  Subsystem  1:  2D  vs  3D  
3.1  Subsystem  Overview  
A  number  of  researchers  have  found  that  cells  cultured  in  3D  matrices  have  a  higher  rate  of  stem  
cell  differentiation  into  neurons,  as  well  as  increased  cell  survival  and  proliferation,  making  
matrix  dimensions  an  ideal  microenvironmental  input  to  add  to  our  model  [20–25] .  
  
  
Figure  3:  Diagram  of  the  2D  versus  3D  Subsystem.  We  collected  data  from  articles  that  put  stem  cells  into  two  
dimensional  and  three  dimensional  matrices  and  measured  neuronal  differentiation  rates.  
  
3.2  Materials  and  Methods  
3.2.1  Literature  Review  and  Data  Collection  
For  each  subsystem,  we  started  our  process  with  literature  review  and  data  collection.  We  used  
various  tools  from  the  SCU  library  to  collect  data,  particularly  using  the  Interlibrary  Loan  system  
to  get  articles  not  owed  by  the  library,  and  library  database  subscriptions,  such  as  Engineering  
Village,  PubMed  and  ScienceDirect  and  Google  Scholar  to  access  other  articles.  We  also  used  
search  techniques  such  as  boolean  operators,  narrowing  down  article  types  and  years,  and  
specifying  keywords  in  the  title  and  abstracts  of  the  papers  to  find  the  articles.  
  
After  finding  the  articles,  we  then  extracted  data  from  the  articles.  If  the  data  was  present  in  
tables,  we  then  immediately  transferred  that  data  into  our  excel  spreadsheet.  However,  in  many  
cases  the  data  was  only  presented  in  graphs  and  figures.  In  that  case,  we  first  reached  out  to  the  
corresponding  author  of  the  paper  to  try  and  get  the  raw  data  from  them.  We  did  not  hear  back  
from  many  of  the  authors,  though.  As  a  result,  when  the  data  was  not  available  we  would  extract  
images  of  the  graphs,  import  the  images  into  Google  Drawings,  and  use  grid  lines  to  closely  
approximate  the  values  and  standard  deviation  (Figure  4).  A  similar  extraction  method  has  been  
used  by  other  researchers  [35–37] .  Using  this  process,  we  collected  data  from  six  papers  on  stem  
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Figure  4:  Diagram  of  the  Data  Extraction  Method  Using  Gridlines  (graph  from  [30] ).  
  
For  our  data  analysis,  we  used  five  out  of  the  six  papers.  These  five  papers  all  used  beta  III  
tubulin  expression,  a  common  neuronal  differentiation  marker,  as  the  measure  of  neuronal  
differentiation  [38] .  We  then  calculated  the  fold  of  beta  III  tubulin  expression  for  the  matrices  
versus  the  control,  using  the  following  formula:  
  
 (Eq.  1)  old change F = control value
experimental value  control value−
  
We  set  a  two  fold  change  from  the  control  as  the  cut  off  between  differentiated  and  
undifferentiated  neurons.  We  made  this  cut-off  based  on  a  paper  by  Gurok  et  al .  who  studied  the  
expression  of  various  markers  over  the  course  of  stem  cell  differentiation  into  neurons  [39] .  They  
found  that  there  was  roughly  a  two  fold  increase  in  beta  III  tubulin  expression  between  stem  cells  
and  differentiated  neurons  [39] .  As  a  result,  we  said  that  samples  with  a  two  fold  or  greater  
increase  compared  to  the  control  were  differentiated,  and  samples  with  less  than  a  two  fold  
increase  were  undifferentiated.  Based  on  these  categories  and  available  data  from  literature  
review,  we  created  a  contingency  table  (Table  3)  for  statistical  analysis.  A  contingency  table  
showcases  the  distributions  of  multiple  variables,  in  this  case  depicting  the  distribution  of  
differentiated  and  undifferentiated  cell  samples  for  both  2D  and  3D  matrices.  
  
Table  3:  Contingency  Table  for  2D  versus  3D  
  
3.2.2  Statistical  Analysis  
We  completed  a  Chi  Square  Test  (𝜒 2 -test)  on  the  data  combined  in  the  contingency  table.  The  
resulting  observed  and  expected  tables  for  the  𝜒 2   -Test  are  located  in  Appendix  A.  We  were  
unable  to  complete  other  forms  of  analysis  that  we  completed  on  the  other  subsystems,  such  as  
the  G  Test  and  Logistic  Regression,  because  of  the  zero  in  the  2D-differentiated  box.  The  zero  
results  in  undefined  values  and  errors  in  the  G  Test  and  Logistic  Regression  computations.  
  
Dimensions  Differentiated  (>2  
fold  increase)  
Undifferentiated  (<2  
fold  increase)  
Total  
2D  0  10  10  
3D  21  7  28  
Total  21  17  38  
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3.2.3.1  Chi  Square  Test  
A  𝜒 2 -test  tests  whether  the  distributions  of  variables  differ  from  one  another.  In  our  case,  it  tests  
the  distributions  of  differentiated  and  undifferentiated  cells  for  2D  versus  3D  matrix  cultures.  
This  test  lets  us  know  if  there  is  a  significant  difference  between  the  experimental  group  and  the  
control  in  terms  of  differentiation  [40] .  The  null  hypothesis  is  that  there  is  no  relationship  
between  matrix  dimensions  and  neural  differentiation,  and  the  alternative  hypothesis  is  that  there  
is  a  relationship  between  dimensions  and  differentiation.   
  
To  complete  the  𝜒 2 -test,  we  compared  the  observed  and  expected  data.  The  observed  data  is  the  
data  in  the  contingency  table,  with  an  individual  value  designated  as  O ij   (observed  count  in  row  i  
and  column  j).  We  computed  the  expected  values  from  the  contingency  table  using  the  following  
formula:  
    (Eq.  2)   E ij = (table sum)
(row sum i)(column sum j)
(expected  value  for  row  i,  column  j)   
  
The  expected  values  should  all  be  at  least  5  to  complete  a  𝜒 2 -test.  However,  one  of  our  values  
(2D-undifferentiated)  was  less  than  5,  at  4.5.  Even  so,  we  still  wanted  to  complete  a  𝜒 2 -test  to  get  
a  rough  estimate  of  whether  there  was  a  significant  difference  between  the  relationships  of  the  
variables.  However,  it  is  important  to  note  that  our  expected  values  did  not  entirely  meet  this  
benchmark.  The  resulting  observed  and  expected  values  are  found  in  Appendix  A.  
  
Next,  we  computed  the  𝜒 2 -value  using  the  following  formula:  
   







(O E ) ij− ij
2
  
Finally,  we  used  MATLAB  to  compute  the  p-value  of  the  𝜒 2 -value  using  the  following  code:  
p=1-chicdf(x 2  value,  degrees  of  freedom),  where  degrees  of  freedom=(i-1)(j-1)  and  i  and  j  are  the  
number  of  rows  and  columns  respectively.  
  
3.3  Results  and  Discussion  
The  p-value  from  the  𝜒 2 -test  is  4.2313*10 -5 .  The  p-value  of  4.2313*10 -5   is  much  lower  than  the  
cutoff  value  of  0.05,  so  we  can  reject  the  null  hypothesis  that  there  is  no  relationship  between  
matrix  dimension  and  neural  differentiation.  These  results  go  along  with  all  the  individual  
papers,  which  all  indicate  that  there  is  a  higher  rate  of  neural  differentiation  in  3D  matrices  
versus  2D  [20–25] .  However,  because  one  of  our  expected  values  does  not  meet  the  benchmark  
of  5,  we  would  want  to  do  further  statistical  analysis  to  confirm  these  results.  Nonetheless,  these  
results  are  promising,  indicating  that  3D  matrices  do  have  a  significant  effect  on  stem  cell  
differentiation  into  neurons.  We  would  want  to  keep  this  in  mind  in  the  development  of  our  
platform.  
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CHAPTER  4:  Subsystem  2:  Toxin  
4.1  Subsystem  Overview  
A  large  body  of  literature  has  shown  that  the  presence  of  particular  compounds  can  influence  
cellular  differentiation,  proliferation  and  death  (Figure  5),  therefore  toxins  are  a  variable  of  
interest  for  our  model  of  developmental  neuronal  toxicity.  Various  factors  such  as  the  
concentration  of  the  compound  and  the  time  at  which  cells  are  exposed  determine  the  
compound's  fate  on  cells  [ 17,40,41 ].   
  
Figure  5:  Diagram  of  the  Toxin  Subsystem.  Toxins  can  can  have  one  or  more  effect(s)  on  cells  
  
4.2  Materials  and  Methods  
4.2.1  Literature  Review  and  Data  Collection  
As  mentioned  in  section  3.2.1  the  first  step  of  each  sub  system  was  a  literature  review  and  data  
collection.  For  the  toxin  exposure  subsystem,  we  began  by  collecting  data  on  two  different  
compounds  previously  shown  to  cause  developmental  toxicity:  acrylamide  and  lead  [ 6,13,39 ].  
During  the  initial  phases  of  literature  review  and  data  collection,  data  was  collected  from  eleven  
papers  for  acrylamide  and  nine  papers  for  lead.   
  
Toxin  data  collected  ended  up  containing  many  different  markers  used  to  measure  the  
differentiation  of  cells,  for  example,  one  group  would  use  the  expression  of  a  particular  gene  
while  another  group  would  use  morphological  characteristics.  Because  different  cell  markers  
appear  at  different  periods  of  cellular  differentiation,  we  are  unable  to  combine  data  of  different  
gene  markers.  Furthermore,  the  timing  of  toxin  addition  proved  to  be  highly  variable  between  
different  groups  which  imposed  further  limitations  when  attempting  to  unify  the  data.   
  
The  changes  in  neurite  length  were  represented  as  percentage  changes  with  reference  to  negative  
control  and  positive  control,  along  with  calculating  fold  change  using  equation  1.  The  negative  
control  was  defined  as  0  uM  Lead   t=0  without  Nerve  Growth  Factor  (NGF)  and  the  positive  
control  was  defined  as  0  uM  Lead  t=0  with  NGF.  Nerve  growth  factor  has  been  shown  to  play  a  
critical  protective  role  in  the  development  and  survival  of  early  neurons,  so  a  culture  without  this  
factor  is  a  suitable  negative  control  [43] .  In  situations  where  negative  control  was  not  present  in  
the  data  set,  it  was  assumed  to  be  zero  fold  change.  
  
*100  (Eq.  4)  ercent Change P = positive control negative control−
experimental value  negative control−
  
To  arrange  the  neurite  extension  data  into  contingency  tables,  we  set  a  one  fold  increase  as  the  
cut  off  between  differentiated  and  undifferentiated  neurons.  This  decision  was  made  because  a  
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one  fold  difference  was  equal  to  the  difference  between  the  positive  and  negative  control  (neurite  
extension  with  and  without  NGF  at  t=0).  This  means  that  any  neurons  that  had  over  a  one  fold  
increase  in  neurite  extension  compared  to  the  negative  control  were  considered  differentiated  and  
any  neurons  that  were  less  than  one  fold  increase  compared  to  the  negative  control  were  
considered  differentiated  for  the  purpose  of  our  contingency  table  (Table  4).   
  
Table  4:  Contingency  Table  for  Toxin  Type  
  
  
4.2.2  Statistical  Analysis  
For  the  toxin  data  that  we  collected  and  combined  into  a  contingency  table,  we  performed  a  
𝜒 2 -test  and  G-test.  For  the  𝜒 2 -test,  we  used  the  same  methodology  described  in  section  3.2.3.1.  
The  resulting  observed  and  expected  tables  for  both  the  𝜒 2   and  G-Test  are  located  in  Appendix  A.  
  
4.2.2.1  G  Test  
The  G-test  of  Independence  is  a  likelihood  ratio  test  that  is  used  to  determine  whether  the  
number  of  observations  in  a  specific  category  fits  the  theoretical  expected  value.  The  G-test  is  
used  when  you  have  one  minimal  variable  with  two  or  more  states  and  it  allows  you  to  see  if  the  
proportions  of  one  variable  different  for  different  values  of  another  variable  [44,45] .   
  
The  test  generates  a  G  statistic  which  can  be  used  to  calculate  a  p-value  to  determine  if  you  can  
accept  or  reject  the  null  hypothesis.  The  null  hypothesis  is  that  there  is  no  relationship  between  
the  presence  of  a  particular  toxin  and  neural  differentiation,  and  the  alternative  hypothesis  is  that  
there  is  a  relationship  between  presence  of  a  particular  toxin  and  neural  differentiation.  To  
perform  the  test,  a  contingency  table  (Table  4)  was  created  as  described  previously  in  section  
3.2.2  and  observed  and  expected  values  for  contingency  tables  for  analysis  along  with  degrees  of  
freedom  were  calculated  in  the  same  manner  as  for  the  𝜒 2 -tests  mentioned  in  section  3.2.3.1.  
Following  the  definitions  of    and  ,  the  G-statistic  was  calculated  as  shown  below  in   O ij  E ij
equation  5.  






O ij E ij
O ij
  
Finally,  using  the  resulting  G-statistic,  a  p-value  is  calculated  in  MATLAB  by  applying  the  
chi-square  cumulative  distribution  function  as  previously  described  in  section  3.2.3.1.  
  
  
Toxin  Concentration  Differentiated  (>1  
fold  increase)  
Undifferentiated  (<1  
fold  increase)  
Total  
0-0.09uM  4  12  16  
0.1-2uM  1  5  6  
Total  5  17  22  
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4.3  Results  and  Discussion  
As  mentioned  in  section  4.2.1,  the  toxin  data  collected  contained  various  different  metrics  of  
differentiation  which  removed  the  option  of  combining  the  data  from  dissimilar  papers.  As  a  
result,  we  were  unable  to  create  a  contingency  table  for  any  of  the  data  collected  by  acrylamide  
papers  and  only  able  to  create  a  contingency  table  for  lead  from  three  of  the  nine  papers  that  we  
reviewed.   
  
The  p-value  from  the  G  test  was  0.6714  indicating  that  we  fail  to  reject  the  null  hypothesis.  The  
p-value  from  the  𝜒 2 -test  was  0.6801  indicating  that  we  fail  to  reject  the  null  hypothesis.  These  
results  are  not  in  agreement  with  published  results,  as  the  papers’  data  used  to  create  the  
contingency  table  found  that  there  was  an  effect  of  lead  on  neural  differentiation.  We  hypothesize  
that  the  differences  in  our  results  from  the  published  work  could  be  caused  by  the  process  of  over  
simplifying  differentiation  as  a  binary  when  creating  our  contingency  table  when  in  fact  there  are  
many  stages  of  differentiation  between  a  stem  cell  and  a  mature,  differentiated  neuron.  
Additionally,  As  mentioned  in  section  3.2.3.1,  the  expected  values  should  all  be  at  least  five  to  
complete  a  G  or  𝜒 2   test  so  the  small  sample  size  may  also  contribute  to  differences  between  the  
literature  and  our  findings.   
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CHAPTER  5:  Subsystem  3:  Stiffness  
5.1  Subsystem  Overview  
The  impact  of  stiffness  on  cell  differentiation  has  been  heavily  investigated  and  is  well  known  to  
influence  cell  fate  [26–33,46] ,  making  it  a  prime  variable  to  incorporate  into  our  predictive  
model.  In  general,  cells  differentiated  on  stiffnesses  less  than  1  kPa  will  express  neurogenic  
biomarkers,  while  those  cultured  on  10  kPa  surfaces  will  express  myogenic  biomarkers  [30]  as  
shown  in  Figure  6.  In  addition,  those  differentiated  on  34  kPa  surfaces  will  express  osteogenic  
biomarkers  [30] .   
  
Figure  6:  Impact  of  Stiffness  on  Fate  of  Stem  Cell  Differentiation  Adapted  from  [30]  
  
5.2  Materials  and  Methods  
5.2.1  Literature  Review  and  Data  Collection  
During  our  literature  review,  we  read  and  collected  data  from  9  papers  analyzing  the  impact  of  
various  2D  culture  stiffness  on  neural  differentiation.  The  same  methodology  for  literature  
review  and  data  extraction  from  graphs  was  followed,  mentioned  in  section  3.2.1.  Researchers  
measured  gene  expression  such  as  beta  III  tubulin,  MAP2  and  GFAP,  as  well  as  neurite  
branching  and  extension  to  analyze  the  impact  of  stiffness  on  neural  differentiation  [26–33,46] . 
For  our  data  analysis,  we  used  data  that  measures  beta  III  tubulin  expression  because  this  was  the  
most  common  metric  across  6  out  of  the  9  papers.  The  stiffness  categories  were  decided  based  on  
Engler  et  al. ’s  research  shown  in  Figure  6  [30] .  The  data  was  decided  if  it  was  differentiated  or  
undifferentiated  using  a  2-fold  threshold  using  the  same  methodology  mentioned  in  section  3.2.2  
[39] .  Based  on  these  categories  and  available  data  from  literature  review,  we  created  a  
contingency  table  (Table  5)  for  statistical  analysis.  
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Table  5:  Contingency  Table  for  Stiffness  Data  
  
5.2.2  Statistical  Analysis   
For  the  stiffness  data  that  we  collected  and  combined  into  a  contingency  table,  we  performed  a  
𝜒 2 -test,  G-test  and  Logistic  regression.  We  performed  Principal  Component  Analysis  (PCA)  on  
an  extensive  dataset  provided  by  Engler  et  al.  in  their  supplementary  materials  that  measures  the  
gene  expression  of  21  neural  lineage  markers  over  various  stiffness  with  and  without  blebbistatin  
(BLEBB),  a  chemical  that  blocks  mechanical  signal  transduction  [30] .   
  
For  the  𝜒 2 -test  and  G-Test,  we  used  the  same  methodology  described  in  section  3.2.3.1  and  
4.2.2.1  respectively.  The  resulting  observed  and  expected  tables  for  both  the  𝜒 2   and  G-Test  are  
located  in  Appendix  A.  
  
5.2.2.1  Logistic  Regression  
Logistic  regression  analysis  examines  the  association  between  categorical  or  continuous  
independent  variables  and  with  one  binary  dependent  variable,  producing  an  odds  ratio  and  p  
value  that  indicates  the  strength  and  direction  of  association  between  the  two  variables  [47] .  This  
method  is  optimal  for  measuring  the  relationship  between  various  stiffnesses,  a  categorical  
independent  variable,  with  differentiation,  a  binary  dependent  variable.  In  order  to  perform  
logistic  regression,  we  used  the  link  function  and  standard  equation  shown  below  [48] .  
  
og xl pi1 p− i = β0 + β1 i (Eq.  6)  
 here i , 2, ... nw = 1  .  
  
After  performing  logistic  regression  and  solving  for  β₀  and  β₁,  equation  6  can  be  rewritten  as  
equation  7  to  solve  for  the  proportion  of  cells  differentiated  per  stiffness  category.   
  
p = exp(β₀ β₁x )− i1+expβ₀ β₁x )− i   (Eq.  7)  
  
We  used  MATLAB  to  perform  logistic  regression,  provided  by  Santa  Clara  University  Design  
Center.  The  data  from  the  contingency  table  was  input  into  MATLAB  as  a  stiffness  matrix  with  
1,  2,  and  3  representing  the  three  stiffness  categories,  the  number  of  data  points  considered  
differentiated  and  the  overall  sample  size  per  category.  Using  the  generalized  linear  model  
  
Stiffness  Differentiated  (>2  
fold  increase)  
Undifferentiated  (<2  
fold  increase)  
Total  
Low  (<1kPa)  3  1  4  
Medium  (1-10kPa)  5  5  10  
High  (>10kPa)  1  5  6  
Total  9  11  20  
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function,  b  values  for  equation  6,  standard  deviation  and  p-values  were  generated.  The  MATLAB  
code  is  private  domain  and  can  not  be  provided  in  this  report.  
  
5.2.2.2  Principal  Component  Analysis  
Principal  Component  Analysis  (PCA)  is  a  helpful  dimensionality  reduction  tool.  PCA  essentially  
identifies  which  variables  are  closely  associated  and  which  are  the  most  unique,  allowing  the  
preservation  of  as  much  variability  as  possible  while  reducing  dimensions  [49,50] .  We  performed  
this  test  to  identify  which  genes  in  Engler  et  al. ’s  dataset  were  the  most  unique  and  should  be  
focused  on  for  future  laboratory  research,  reducing  the  number  of  future  experiments  that  need  to  
be  run.   
  
In  order  to  conduct  PCA,  z-scores  are  computed  for  each  variable  (X k ),  the  covariance  matrix  is  
computed  from  the  z-scores,  eigenvectors  are  computed  from  the  covariance  matrix  (V(λ k )),  then  
reduced  dimensionality  is  computed  using  the  following  transformed  equation  [49,50] :   
  
   (Eq.  8)  CA (λ )P = ∑
n
K=0
V k * Xk
  
We  analyzed  a  dataset  from  Engler  et  al.  that  measures  the  gene  expression  of  21  neural  lineage  
markers  over  various  culture  stiffnesses  ranging  from  0.1kPa  to  34kPa  [30] .  Engler  et  al.'s  
dataset  is  located  in  Appendix  B.  We  used  MATLAB  to  run  PCA.  The  code  is  private  domain  
and  is  not  provided  in  this  report.  Although  we  ran  several  iterations,  our  final  analysis  focused  
on  the  dataset  without  the  addition  of  BLEBB  since  we  are  interested  in  how  mechanical  signals  
influence  cell  fate.   
  
After  running  our  MATLAB  code,  two  graphs  were  generated.  The  first  graph  is  the  Pareto  of  
Effects,  a  bar  graph  which  graphs  percent  of  variance  over  variance.  This  graphic  indicates  how  
many  distinct  clusters  of  variables  exist  in  the  dataset  after  dimensionality  reduction  and  what  
percent  of  variance  the  corresponding  cluster  represents  in  the  dataset  [51] .  The  second  graph  is  a  
biplot,  which  graphs  each  gene  where  the  cosine  of  the  angle  between  the  gene  and  axis  indicates  
its  importance  [49] .  The  cosine  of  the  angle  between  pairs  of  genes  indicates  their  correlation  
[49] .  Genes  with  high  correlations  will  point  in  similar  directions  and  can  be  stacked,  while  
genes  with  low  correlations  will  have  large  angles  and  can  be  perpendicular  to  each  other  [49] .  
  
5.3  Results  and  Discussion  
The  𝜒 2 -test  had  a  p-value  of  0.1736,  while  the  G-Test  had  a  p-value  of  0.15.  Both  of  these  values  
are  well  above  the  level  of  significance  (p=0.05),  therefore  we  did  not  reject  the  null  hypothesis,  
which  states  that  there  is  no  association  between  stiffness  and  differentiation.   
  
Logistic  regression  yielded  the  following  model,  where  xi  corresponds  to  1,  2  or  3  depending  on  
the  stiffness  category  and  p  is  the  proportion  differentiated:  
     (Eq.  9)  p = exp(2.64 1.37x )− i1+exp(2.64 1.37x )− i
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Equation  9  has  a  negative  slope,  indicating  an  inverse  correlation  between  the  variables.  As  
stiffness  increases,  the  odds  of  neural  differentiation  decreases,  as  seen  in  Figure  7.  This  trend  
was  expected  based  on  previous  literature  [26–31] .   
  
Figure  7:  Graph  of  Logistic  Regression  Model  (logit)  Compared  to  Observed  Values  Extracted  from  Stiffness  
Contingency  Table.   
  
MATLAB  generated  p-values  of  0.0847  and  0.1218  for  the  two  coefficients  incorporated  into  the  
logistic  regression  model.  Neither  of  the  p  values  are  significant  with  an  alpha  of  0.05,  therefore  
we  fail  to  reject  the  null  hypothesis.   
  
These  results  from  the  𝜒 2 -test,  G-test  and  logistic  regression  were  unexpected  because  all  
literature  incorporated  into  our  contingency  table  significantly  showed  that  stiffness  influences  
neural  differentiation  [26–31] .  As  mentioned  in  Chapters  1,  3  and  4,  the  expected  value  in  each  
category  must  be  greater  than  5  in  order  for  the  statistical  tests  to  accurately  reflect  the  data.  
  
After  running  our  PCA  script,  the  Pareto  of  Effects  bar  graph  identified  3  unique  clusters  of  
genes  shown  in  Figure  8.  Cluster  1  makes  up  roughly  80%  of  the  variance  in  the  dataset,  while  
cluster  2  and  3  consist  of  20%  of  the  variance.   
  
Figure  8:  Pareto  of  Effect  Representing  Unique  Clusters  in  PCA  Data  Set  from  Engler  et  al.  [30]   
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The  generated  biplot  identifies  which  genes  belong  to  the  three  significant  clusters  as  well  as  
their  importance  shown  in  Figure  9.  N-Cadherin  is  the  most  distinctly  unique  gene  with  the  
largest  cosine  of  the  angle  between  the  gene  and  x-axis.  N-Cadherin  is  commonly  known  as  an  
adhesive  protein,  but  it  is  also  used  by  cells  to  promote  neural  differentiation  and  stabilize  neural  
identity  by  dampening  anti-neural  signals  [52] .  The  middle  cluster  contains  13  genes,  indicating  
these  are  relatively  similar  and  only  one  from  this  cluster  needs  to  be  investigated  in  future  
research.  The  bottom  cluster  contains  3  genes,  Neural  Cell  Adhesion  Molecule  (CAM)  1  being  
the  most  significant  due  to  the  largest  cosine  angle  value.  Neural  CAM  1  influences  neuronal  
migration,  axonal  branching  and  synaptogenesis  [53] .  The  red  dots  represent  outliers  in  the  data  
set  identified  from  the  PCA.  Engler  et  al. ’s  dataset  did  not  have  any  replicates,  therefore  no  
formal  outlier  analysis  was  conducted.  In  future  experiments,  N-Cadherin,  Neural  CAM  1  and  
one  gene  of  choice  from  the  middle  cluster  should  be  focused  on.   
   
      
Figure  9:  PCA  Biplot  Indicating  Important  Genes   
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CHAPTER  6:  Engineering  Standards 
6.1  Ethical  Justification  
As  engineers,  we  understand  that  it  is  vital  to  consider  the  ethical  implications  of   our  work.  We  
have  three  main  ethical  justifications  for  our  project.  First,  by  consolidating  and  analyzing  a  wide  
variety  of  sources  on  the  impact  of  substrate  stiffness,  matrix  dimensions  and  neurotoxins  on  
neural  differentiation,  we  hope  to  help  others  reduce  the  number  of  experiments  that  they  need  to  
complete  on  neural  cells.  This  will  allow  more  researchers  to  complete  research  on  neurons,  as 
they  will  not  be  as  prohibited  by  cost,  which  in  turn  will  produce  more  data  on  developmental  
toxicity.  As  more  research  is  done  on  this  topic,  we  will  be  able  to  better  understand  the  impact  
of  these  toxins  on  the  brain,  and  reduce  exposure  to  such  toxins  in  commercial  products.  Further,  
reducing  the  number  of  experiments  will  reduce  the  number  of  stem  cells  that  need  to  be  used  for  
research  purposes.  
  
Second,  our  project  will  allow  researchers  to  begin  to  shift  away  from  animal  models.  This  shift  
allows  researchers  to  better  understand  the  workings  of  the  human  brain,  as  animal  models  do  
not  mimic  human  brain  development  well  [54] .  This  will  further  improve  the  quality  of  research  
being  done  on  brain  development  and  developmental  neurotoxicity.  Further,  moving  away  from  
animal  models  removes  the  ethical  quandaries  regarding  animal  research.  While  there  are  ethical  
justifications  for  using  animal  models,  such  as  the  benefits  to  human  health,  moving  away  from  
these  models  will  open  up  these  benefits  to  more  people  who  may  feel  repulsed  by  benefiting  
from  animal  research  [55] .   
  
Third,  we  believe  that  the  choice  of  project  itself,  studying  developmental  neurotoxicity,  is  
ethically  justified.  Developmental  neurotoxins  can  have  large  impacts  on  brain  development,  
resulting  in  various  neurological  disorders  later  in  life  [56] .  As  a  result,  we  believe  that  the  time  
and  energy  invested  in  this  project  will  have  benefits  for  many  people  because  it  will  help  open  
the  doors  for  more  research  and  understanding  on  developmental  neurotoxicity.  Further,  our  
findings  on  the  impact  substrate  stiffness  and  dimensions  on  neural  differentiation  can  aid  in  
other  neurological  research,  not  only  developmental  toxicity,  broadening  the  applicability  of  our  
research.  
  
6.2  Environmental  and  Sustainability  Implications  
As  mentioned  in  the  Ethics  section,  our  project  will  ideally  be  used  by  other  researchers  to  
reduce  the  number  of  experiments  and  animal  models  needed  to  be  completed  for  research  on  
developmental  neurotoxicity.  By  reducing  the  number  of  experiments  needed,  we  will  reduce  the  
environmental  impact  of  researching  developmental  neurotoxicity.  Further,  animal  research  has  a  
large  environmental  impact,  so  reducing  the  need  for  animal  models  will  make  developmental  
neurotoxicity  research  more  sustainable  [57] .  
  
6.3  Economic  Considerations  
By  reducing  the  need  for  animal  models  and  the  number  of  experiments,  it  will  make  
developmental  toxicity  research  more  economically  feasible.  Reducing  the  number  of  animal  
models  will  reduce  the  cost  of  developmental  toxicity  research,  as  animal  research  comes  with  
many  costs,  such  as  creation  of  facilities  to  house  and  care  for  the  animals  [58] .  Reducing  the  
number  of  experiments  will  decrease  the  cost  of  completing  research  as  well,  as  people  will  have  
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to  purchase  fewer  materials  and  spend  less  time.  As  a  result,  our  project  will  have  positive  
economic  impacts.  
  
6.4  Health  and  Safety  Implications   
As  discussed  in  section  1.1.1,  using  two-dimensional  cells  cultured  during  drug  development  has  
shown  to  be  ineffective  due  to  culturing  conditions  that  are  not  similar  to  the  in  vivo  
environment,  affecting  proliferation  and  differentiation.  Our  project  represents  a  more  relevant  
way  to  study  developmental  toxicity  than  currently  available  methods  by  using  
three-dimensional  cell  culture.  Which  in  turn  will  further  improve  safety  of  pharmaceutical  drugs  
and  other  biotechnology  products,  as  researchers  will  be  able  to  better  and  more  relevantly  
evaluate  if  materials  or  compounds  are  developmental  toxins.   
  
6.5  Social  and  Political  Considerations   
Federal  government  is  the  primary  source  of   research  and  development  funding;  the  NIH  alone  
invests  41.7  billion  dollars  each  year  into  medical  research,  much  of  which  is  related  to  drug  
development  [59] .  If  proved  effective,  our  model  could  serve  as  a  pre-screening  tool  for  drug  
development.  This  would  greatly  reduce  the  number  of  experiments  required  to  bring  a  product  
or  material  to  market  and  therefore  reduce  the  cost  of  research  and  development  to  taxpayers.  
Additionally,  as  many  developmental  toxicology  studies  make  use  of  stem  cells,  some  cell  lines  
have  ethical  sourcing  complications.  Our  project  has  additional  social  considerations  as  it  
reduces  the  use  of  these  types  of  cells  during  experimentation.   
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CHAPTER  7:  Summary  and  Conclusions  
7.1  Summary  of  the  Project  
Our  senior  design  project  had  three  main  stages.  The  first  stage  was  literature  review.  In  this  
stage,  we  researched  the  current  available  methods  to  study  developmental  toxicity  as  well  as  the  
different  microenvironmental  factors  that  impact  neuronal  differentiation.  From  this  initial  
search,  we  narrowed  down  our  pool  of  microenvironmental  inputs  to  three  main  inputs:  matrix  
stiffness,  matrix  dimensions,  and  toxin  addition.  The  next  stage  of  our  project  was  data  
collection.  We  extracted  data  from  over  fifty  papers  on  the  impact  of  various  factors  on  stem  cell  
differentiation.  We  then  combined  the  data  from  papers  with  comparable  experimental  methods  
into  contingency  tables.  After  data  collection,  we  moved  on  to  the  final  stage  of  our  project:  data  
analysis.  We  completed  𝜒 2 -  and  G-tests  to  determine  significance  of  the  microenvironment  
inputs.  We  also  completed  logistic  regression  to  determine  the  correlation  between  stiffness  and  
differentiation.  Further,  we  used  PCA  to  reduce  the  number  of  variables,  thus  simplifying  further  
experimentation  on  neuronal  differentiation.  However,  the  only  microenvironment  input  that  was  
significant  according  to  our  tests  was  matrix  dimensions.  This  result  was  surprising  because  our  
literature  review  indicated  that  both  stiffness  and  toxin  addition  have  an  impact  on  stem  cell  
differentiation  into  neurons  [26–31] .  We  believe  that  this  is  due  to  our  small  sample  sizes.  As  a  
result,  we  would  like  to  do  further  research  into  this  field.  
  
7.2  Systems  Integration  and  Future  Work  
In  order  to  integrate  the  aforementioned  subsystems,  future  work  will  need  to  be  done  to  increase  
the  sample  size  per  category  in  the  matrix  dimension,  toxin,  and  stiffness  contingency  tables.  For  
variables  that  have  a  statistically  significant  influence  on  neural  differentiation,  these  will  be  
incorporated  into  our  final  predictive  models.  The  goal  of  our  project  is  to  create  two  models  as  
diagrammed  in  Figure  10.   
  
  
Figure  10:  Diagram  of  Two  Predictive  Models  to  Predict  Cell  Fate  and  Toxin  Type  
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In  the  first  model,  researchers  will  input  data  on  selected  microenvironmental  cues  of  which  stem  
cells  will  be  subjected  to.  Then,  the  model  will  predict  cell  fate  such  as  differentiation  into  
neurons  or  other  cell  types,  no  occurrence  of  differentiation  or  occurrence  of  apoptosis  or  
necrosis.  In  the  second  model,  data  regarding  the  cell  fate  such  as  morphology,  cell  viability,  
proliferation  and  gene  or  protein  expression  will  be  inputed.  This  data  can  take  the  form  of  
neurite  length,  alive/dead  cell  counts  or  important  biomarkers  derived  from  literature  or  our  PCA  
analysis  such  as  beta  III  tubulin,  N-Cadherin  or  Neural  CAM  1.  Once  the  data  is  input  into  the  
model,  it  should  predict  the  toxin  type  added  to  the  system  which  can  include  developmental  
toxins,  neural  toxins,  stem  cell  toxins  or  no  toxins.  These  two  models  can  be  used  individually  or  
as  a  system  to  predict  the  influence  of  a  chemical  on  neural  differentiation,  each  providing  
important  information  on  cell  fate  and  toxin  type  respectively.   
  
In  order  to  complete  the  predictive  models,  there  is  more  work  to  be  done  in  the  future.  First,  we  
would  generate  more  data  in  the  lab  regarding  the  impact  of  stiffness  and  toxin  addition  on  stem  
cell  differentiation  to  fill  in  the  holes  in  our  data  collection  from  literature.  Additionally,  we  
would  like  to  collect  data  on  other  variables  such  as  diffusion  and  adhesion  sites  on  stem  cell  
differentiation  from  literature.  Then,  we  would  continue  to  fill  in  gaps  in  the  contingency  tables  
by  generating  data  from  the  lab.  Second,  we  would  begin  to  develop  the  predictive  models  using  
statistical  analysis  of  the  lab  generated  data  and  the  data  from  papers.  The  goal  is  to  have  two  
models:  one  where  researchers  input  microenvironmental  cues  and  the  model  predicts  the  stem  
cell  differentiation,  and  another  where  researchers  input  cell  characteristics  and  the  model  
outputs  toxin  type.  Finally,  we  would  validate  the  models  in  the  lab  to  ensure  that  they  accurately  
predict  stem  cell  differentiation  and  toxin  type.  
  
7.3  Lessons  Learned  
Our  team  learned  a  number  of  invaluable  lessons  from  this  project.  First,  we  increased  our  
proficiency  in  literature  research.  We  learned  how  to  use  various  search  techniques  and  data  
bases  to  get  a  wide  variety  of  sources  that  apply  to  our  research.  Second,  we  improved  our  data  
analysis  techniques.  We  were  able  to  practice  χ 2 -tests  and  logistic  regression,  which  we  had  
learned  in  prior  courses.  Further,  we  learned  new  techniques  such  as  G-tests  and  PCA,  which  we  
will  be  able  to  use  for  future  research  projects.  Finally,  throughout  this  process,  we  improve  our  
teamwork  and  communication  skills,  figuring  out  how  to  allocate  work  well.  All  of  these  skills 
will  be  indispensable  as  we  all  move  forward  in  our  careers.  
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APPENDIX  
  
Appendix  A:  Observed  and  Expected  Tables  for  𝜒 2 -test  and  G-Test  
  
A.1  𝜒 2 -Test  Observed  and  Expected  Tables  for  2D  versus  3D  
  
Table  7:  Observed  Values  for  2D  versus  3D  Contingency  Table  
  
Table  8:  Expected  Values  for  2D  versus  3D  Contingency  Table  
  




   
  
Observed  2D  3D  Total  
Differentiated  (>2  fold  
increase)  0  21  21  
Undifferentiated  (<2  
fold  increase)  10  7  17  
Total  10  28  38  
Expected  2D  3D  Total  
Differentiated  (>2  fold  
increase)  5.5  15.5  21.0  
Undifferentiated  (<2  
fold  increase)  4.5  12.5  17.0  
Total  10.0  28.0  38.0  
𝜒 2 -Test  2D  3D  
Differentiated  (>2  fold  increase)  5.53  1.97  
Undifferentiated  (<2  fold  increase) 6.83  2.44  
  𝝌²  16.76  
  p  4.23E-05  
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A.2  𝜒 2   and  G-Test  Observed  and  Expected  Tables  for  Toxin  
  
  
Table  10:  Observed  Values  for  Toxin  Contingency  Table  
  
Table  11:  Expected  Values  for  Toxin  Contingency  Table  
  
Table  12:  𝜒  2 -Test  Values  for  Toxin   
  
   
  
Observed  0-0.09uM  0.1-2uM  Total  
Undifferentiated  (<1  
Fold)  12  5  17  
Differentiated  (>1  Fold) 4  1  5  
Total  16  6  22  
Expected  0-0.09uM  0.1-2uM  Total  
Undifferentiated  (<1  
Fold)  12.36  4.64  17  
Differentiated  (>1  Fold) 3.64  1.36  5  
Total  16  6  22  
𝜒 2 -Test  0-0.09uM  0.1-2uM  
Undifferentiated  (<1  Fold)  0.01  0.03  
Differentiated  (>1  Fold)  0.04  0.10  
  𝝌²  0.17  
  p  0.6801  
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Table  13:  G-Test  Values  for  Toxin   
  
A.3  𝜒 2   and  G-Test  Observed  and  Expected  Tables  for  Stiffness  
  
Table  14:  Observed  Values  for  Stiffness  Contingency  Table  
  
Table  15:  Expected  Values  for  Stiffness  Contingency  Table  
  
  
   
  
G-Test  0-0.09uM  0.1-2uM  
Undifferentiated  (<1  Fold)  -0.36  0.38  
Differentiated  (>1  Fold)  0.38  -0.31  
  G  0.18  
  p  0.6714  
Observed  Low  (<1kPa)  Medium  (1-10kPa) High  (>10kPa)  Total  
Differentiated  (>2  fold  
increase)  3  5  1  9  
Undifferentiated  (<2  fold  
increase)  1  5  5  11  
Total  4  10  6  20  
Expected  Low  (<1kPa)  Medium  (1-10kPa) High  (>10kPa)  Total  
Differentiated  (>2  fold  
increase)  1.8  4.5  2.7  9  
Undifferentiated  (<2  fold 
increase)  2.2  5.5  3.3  11  
Total  4  10  6  20  
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Table  16:  𝜒  2 -Test  Values  for  Stiffness   
  
Table  17:  G-Test  Values  for  Stiffness  
  
   
  
𝜒 2 -Test  Low  (<1kPa)  Medium  (1-10kPa)  High  (>10kPa)  
Differentiated  (>2  fold  
increase)  0.80  0.06  1.07  
Undifferentiated  (<2  
fold  increase)  0.65  0.05  0.88  
    𝝌²  3.50  
    p  0.1736  
G-Test  Low  (<1kPa)  Medium  (1-10kPa)  High  (>10kPa)  
Differentiated  (>2  fold  
increase)  1.53  0.53  -0.99  
Undifferentiated  (<2  fold 
increase)  -0.79  -0.48  2.08  
    G  3.76  
    p  0.15  
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Appendix  B:  Principal  Component  Analysis  Dataset  
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Appendix  C:  Proposed  Budget  and  Finalized  Budget  
C.1  Proposed  Budget  
Table  19:  Hydrogel  Materials  
  
Table  20:  Cell  Culture  and  Differentiation  Materials  
  
C.2  Finalized  Budget  
Table  21:  Finalized  Budget  and  Materials  Used  for  Senior  Design  2021  
  
  
Material  Source  Quantity  Cost  
Alginate  Abcam  1  kit  (good  for  100  
tests)  
$505  
Crosslinker  -  Collagen  Sigma  Aldrich  30  mg  $241  
Acrylamide  Sigma  Aldrich  100  mL  $43  
Material  Source  Quantity  Cost  
P19  Cells  Dr.  Zhang’s  Lab      
Dissociation  Reagent  
trypsin-  EDTA  
Thermofisher  100  mL  $15  
  α-MEM  Thermofisher  1  L  $110  
T-75  Flasks  Thermofisher  100  flasks  $337  
Fetal  calf  serum  Thermofisher  100  mL  $171  
Newborn  calf  serum  Thermofisher  100  mL  $32  
Dulbecco’s  PBS  
without  calcium  and  
magnesium  
Thermofisher  1  L  $49  
All  trans-retinoic  acid  Sigma  Aldrich  100  mg  $47  
    Total  $1550  
Material  Source  Quantity  Cost  
MATLAB  SCU  Engineering  Design  Center  N/A  $0  
Journal  Databases  SCU  Library  N/A  $0  
Google  Suite  SCU  N/A  $0  
    Total  $0  
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Appendix  D:  Project  Schedule  
Figure  11:  Gantt  Chart  of  Senior  Design  Project  Progress  
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